The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community
Abstract
Background— Information is limited regarding the rates of progression to congestive heart failure (CHF) and death in individuals with asymptomatic left ventricular systolic dysfunction (ALVD). We sought to characterize the natural history of ALVD, by studying unselected individuals with this condition in the community. Methods and Results— We studied 4257 participants (1860 men) from the Framingham Study who underwent routine echocardiography. The prevalence of ALVD (visually estimated ejection fraction [EF]≤50% without a history of CHF) was 6.0% in men and 0.8% in women. During up to 12 years of follow-up, rates of CHF among subjects with normal left ventricular systolic function (EF >50%, n=4128) and ALVD (n=129) were 0.7 and 5.8 per 100 person-years, respectively. After adjustment for cardiovascular disease risk factors, ALVD was associated with a hazards ratio (HR) for CHF of 4.7 (95% CI 2.7 to 8.1), compared with individuals without ALVD. An elevated risk of CHF after ALVD was observed even in individuals without prior myocardial infarction or valvular disease, with an adjusted HR of 6.5 (CI 3.1 to 13.5). Mild ALVD (EF 40% to 50%, n=78) and moderate-to-severe ALVD (EF <40%, n=51) were associated with adjusted HRs for CHF of 3.3 (CI 1.7 to 6.6) and 7.8 (CI 3.9 to 15.6), respectively. ALVD was also associated with an increased mortality risk (adjusted HR 1.6, CI 1.1 to 2.4). The median survival of ALVD subjects was 7.1 years. Conclusion— Individuals with ALVD in the community are at high risk of CHF and death, even when only mild impairment of EF is present. Additional studies are needed to define optimal therapy for mild ALVD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, there are no strategies to identify individuals at risk of developing SHDs, despite the presence of evidence-based interventions that can alter the course of patients.6-8”
From Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images (2025) · cites this paper as [8]
In the citing paper
“Recent guidelines have a notable emphasis on the detection of asymptomatic ventricular dysfunction (“stage B heart failure”) as part of efforts to understand and prevent overt heart failure.61”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [61]
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,874
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Cited by
Sorted by citations
Items 201–300 of 633
Current Perspectives on Diagnosis of Heart Failure in Long-term Dialysis Patients
Wang, A. Y.-M., & Sanderson, J. E. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.07.019 · Cited by 35
Early and asymptomatic cardiac dysfunction in chronic kidney disease
Chinnappa, S., White, E., Lewis, N. T., Baldo, O., Tu, Y., Glorieux, G., Vanholder, R. C., Nahas, M. E., & Mooney, A. F. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx064 · Cited by 34
Sieswerda, E., van Dalen, E. C., Postma, A., Cheuk, D. K., Caron, H. N., & Kremer, L. C. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008011.pub2 · Cited by 33
Hyperuricemia and the Echocardiographic Measures of Myocardial Dysfunction
Krishnan, E., Hariri, A., Dabbous, O. H., & Pandya, B. J. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00259.x · Cited by 33
Prevalence and Aetiology of Heart Failure in Patients Seen at a Teaching Hospital in Ghana
Owusu, I. K. (2013) · Journal of Cardiovascular Diseases & Diagnosis · doi:10.4172/2329-9517.1000131 · Cited by 32
Biometric contrastive learning for data-efficient deep learning from electrocardiographic images
Sangha, V., Khunte, A., Holste, G., Mortazavi, B. J., Wang, Z., Oikonomou, E. K., & Khera, R. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae002 · Cited by 30
Pugliese, N. R., Fabiani, I., Carrubba, S. L., Conte, L., Antonini‐Canterin, F., Colonna, P., Caso, P., Benedetto, F. A., Santini, V., Carerj, S., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.018 · Cited by 32
Gong, F. F., Campbell, D. J., & Prior, D. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.11.001 · Cited by 32
Muraru, D., Badano, L. P., Ermacora, D., et al. (2011) · International journal of cardiac imaging · doi:10.1007/s10554-011-9985-0 · Cited by 31
Comparative values of gated blood-pool SPECT and CMR for ejection fraction and volume estimation
Sibille, L., Bouallègue, F. B., Bourdon, A., Micheau, A., Vernhet‐Kovacsik, H., & Mariano‐Goulart, D. (2010) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32834155f1 · Cited by 31
Aminorroaya, A., Dhingra, L. S., Pedroso, A. F., Shankar, S. V., Coppi, A. C., Khunte, A., Foppa, M., Brant, L. C., Barreto, S. M., Ribeiro, A. L. P., et al. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaf034 · Cited by 32
Georgiopoulou, V. V., Kalogeropoulos, A. P., & Butler, J. (2012) · Drugs · doi:10.2165/11631100-000000000-00000 · Cited by 30
Medina‐Lezama, J., Narvaez-Guerra, O. D., Herrera-Enriquez, K. B., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009259 · Cited by 29
Lai, C., Chien, K., Hsu, H., et al. (2010) · Echocardiography · doi:10.1111/j.1540-8175.2009.01072.x · Cited by 29
Subclinical pulmonary congestion is prevalent in nephrotic syndrome
Marino, F. V., Martorano, C., Tripepi, R., et al. (2015) · Kidney International · doi:10.1038/ki.2015.279 · Cited by 29
Nasir, K., Rosen, B. D., Kramer, H., Edvardsen, T., Bluemke, D. A., Liu, K., & Lima, J. A. C. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.12.025 · Cited by 29
Ward, R. P., Goonewardena, S. N., Lammertin, G., & Lang, R. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.102 · Cited by 28
Visibility graph analysis of heart rate time series and bio-marker of congestive heart failure
Bhaduri, A., Bhaduri, S., & Ghosh, D. C. (2017) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2017.04.091 · Cited by 30
Blood Signature of Pre-Heart Failure: A Microarrays Study
Smih, F., Desmoulin, F., Berry, M., Turkieh, A., Harmancey, R., Iacovoni, J. S., Trouillet, C., Delmas, C., Pathak, A., Lairez, O., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020414 · Cited by 28
Parikh, N. I., Lloyd‐Jones, D. M., Ning, H., Ouyang, P., Polak, J. F., Lima, J. A. C., Bluemke, D. A., & Mittleman, M. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.12.011 · Cited by 26
Katsushika, S., Kodera, S., Nakamoto, M., Ninomiya, K., Inoue, S., Sawano, S., Kakuda, N., Takiguchi, H., Shinohara, H., Matsuoka, R., et al. (2021) · International Heart Journal · doi:10.1536/ihj.21-407 · Cited by 25
Costello‐Boerrigter, L. C., Boerrigter, G., Ameenuddin, S., Mahoney, D. W., Slusser, J. P., Heublein, D. M., Redfield, M. M., Rodeheffer, R. J., Olson, T. M., & Burnett, J. C. J. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0708 · Cited by 26
Mehta, A., Kondamudi, N., Laukkanen, J. A., Wisløff, U., Franklin, B. A., Arena, R. A., Lavie, C. J., & Pandey, A. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.11.004 · Cited by 28
Recognizing and Managing Asymptomatic Left Ventricular Dysfunction
Albert, N. M., & Lewis, C. M. (2008) · Critical Care Nurse · doi:10.4037/ccn2008.28.2.20 · Cited by 26
Naghavi, M., Reeves, A. P., Budoff, M. J., Li, D., Atlas, K., Zhang, C., Atlas, T., Roy, S. K., Henschke, C. I., Wong, N. D., et al. (2024) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2024.04.006 · Cited by 27
Self-citationHirashiki, A., Izawa, H., Somura, F., Obata, K., Kato, T., Nishizawa, T., Yamada, A., Asano, H., Ohshima, S., Noda, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.069 · Cited by 25
Blaes, A. H., Thavendiranathan, P., & Moslehi, J. J. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_208509 · Cited by 25
Shah, P., Garris, R., Abboud, R., Vasudev, R., Patel, H., Doshi, R. P., Shamoon, F. E., & Bikkina, M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.046 · Cited by 26
Kardys, I., Deckers, J. W., Stricker, B. H. C., Vletter, W. B., Albert Hofman, D., & Witteman, J. C. M. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9453-5 · Cited by 24
Chronic Subcutaneous Brain Natriuretic Peptide Therapy in Asymptomatic Systolic Heart Failure
McKie, P. M., Schirger, J. A., Benike, S. L., Harstad, L. K., Slusser, J. P., Hodge, D. O., Redfield, M. M., Burnett, J. C. J., & Chen, H. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.468 · Cited by 24
Satô, M., Kodera, S., Setoguchi, N., Tanabe, K., Kushida, S., Kanda, J., Saji, M., Nanasato, M., Maki, H., Fujita, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0216 · Cited by 31
Characteristics of Trabeculated Myocardium Burden in Young and Apparently Healthy Adults
Tizón‐Marcos, H., Ricapito, M. D. L. P., Pîbarot, P., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.025 · Cited by 24
Heart Failure with Mid-Range Ejection Fraction - State of the Art
Mesquita, E. T., Barbetta, L. M. D. S., & Correia, E. T. D. O. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190079 · Cited by 23
Left Ventricular Ejection Fraction Assessment in Older Adults
deFilippi, C. R., Christenson, R. H., Kop, W. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.042 · Cited by 23
Models of cardiac hypertrophy and transition to heart failure
Berry, J. M., Naseem, R. H., Rothermel, B. A., & Hill, J. A. (2007) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2007.06.003 · Cited by 23
Pandhi, J., Gottdiener, J. S., Bartz, T. M., Kop, W. J., & Mehra, M. R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.051 · Cited by 23
Amiodarone-Induced Thyrotoxicosis
Censi, S., Bodanza, V., Manso, J., Gusella, S., Watutantrige‐Fernando, S., Cavedon, E., Barollo, S., Bertazza, L., Cecchin, D., & Mian, C. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002207 · Cited by 23
Tsai, D.-J., Lin, C., Liu, W.-T., Lee, C.-C., Chang, C.-H., Lin, W.-Y., Liu, Y.-L., Chang, D.-W., Hsieh, P.-H., Tsai, C.-S., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04190-z · Cited by 19
Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
Ni, H., Jordan, E., Kinnamon, D. D., Cao, J., Haas, G. J., Hofmeyer, M. R., Kransdorf, E. P., Ewald, G. A., Morris, A. A., OWENS, A. T., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.419 · Cited by 22
Chemotherapy‐related cardiomyopathy: a neglected aspect of cancer survivorship
Nolan, M. T., Lowenthal, R. M., Venn, A., & Marwick, T. H. (2014) · Internal Medicine Journal · doi:10.1111/imj.12532 · Cited by 22
Kishi, S., Armstrong, A. D. C., Gidding, S. S., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.052 · Cited by 22
Stoodley, P. W., Richards, D. A. B., Meikle, S. R., Clarke, J., Hui, R., & Thomas, L. (2010) · Heart Lung and Circulation · doi:10.1016/j.hlc.2010.09.007 · Cited by 22
Role and Optimal Dosing of Angiotensin-Converting Enzyme Inhibitors in Heart Failure
Kazi, D. S., & Deswal, A. M. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.12.001 · Cited by 22
Dounousi, E. C., Bouba, I., Spoto, B., Pappas, K. D., Tripepi, G. L., Georgiou, I. A., Tselepis, A. D., Elisaf, M., Tsakiris, D., Zoccali, C., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1507270 · Cited by 22
Abumayyaleh, M., El‐Battrawy, I., Behnes, M., Borggrefe, M. M., & Akın, İ. (2020) · Future Cardiology · doi:10.2217/fca-2020-0002 · Cited by 22
Ayman, K. M. H., Mahmoud, A. A., Eman, A. A.-M., Marwa, S., Mona, M. S., & Yehia, T. (2021) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00037-0 · Cited by 22
Sieswerda, E., Kremer, L. C. M., Vidmar, S., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22371 · Cited by 21
Fabiani, I., Pugliese, N. R., Carrubba, S. L., et al. (2017) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2017.05.005 · Cited by 21
Cappellani, D., Papini, P., Certo, A. M. D., Morganti, R., Urbani, C., Manetti, L., Tanda, M. L., Cosentino, G., Marconcini, G., Materazzi, G., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa464 · Cited by 21
Lala, A., Beavers, C. J., Blumer, V. L., Brewer, L. C., Oliveira-Gomes, D. D., Dunbar, S. B., Every, H., Ferraro, R., Ky, B., Januzzi, J. L., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.06.013 · Cited by 26
Huang, H., Lin, L., Yu, H., et al. (2009) · EP Europace · doi:10.1093/europace/eup294 · Cited by 20
Breast Cancer and Heart Failure
Almuwaqqat, Z., Meisel, J. L., Barac, A., & Parashar, S. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.08.007 · Cited by 20
Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart Failure
Halabi, A., Yang, H., Wright, L. M., Potter, E. L., Huynh, Q. L., Negishi, K., & Marwick, T. H. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.09.032 · Cited by 20
Yamaguchi, M., Tsuruda, T., Watanabe, Y. S., et al. (2013) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-11-19 · Cited by 20
Thomas, J. D., Edvardsen, T., Abraham, T. P., Appadurai, V., Badano, L. P., Banchs, J. A., Cho, G., Cosyns, B., Delgado, V., Donal, E., et al. (2026) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeag006 · Cited by 24
Manzi, M. V., Mancusi, C., Lembo, M., Esposito, G., Rao, M. A. E., SIMONE, G. D., Morisco, C., Trimarco, V., Izzo, R., & Trimarco, B. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13908 · Cited by 19
Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis
Cappellani, D., Bartalena, L., & Bogazzi, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02168-3 · Cited by 19
Russo, C. A., Jin, Z., Homma, S., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.02.011 · Cited by 19
Abdalla, M., Akwo, E. A., Bluemke, D. A., Lima, J. A. C., Shimbo, D., Maurer, M. S., & Bertoni, A. G. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.040 · Cited by 19
Sawano, S., Kodera, S., Setoguchi, N., Tanabe, K., Kushida, S., Kanda, J., Saji, M., Nanasato, M., Maki, H., Fujita, H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307978 · Cited by 20
Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age
Sobel, B. E., Lee, Y., Pratley, R. E., & Schneider, D. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.05.011 · Cited by 18
Sugihara, M., Odagiri, F., Suzuki, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055514 · Cited by 18
Zhang, Q. B., Sun, J. P., Gao, R. F., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.171 · Cited by 18
Takamatsu, H., Tada, H., Okaniwa, H., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.120 · Cited by 18
MADIT-CRT — Breathtaking or Time to Catch Our Breath?
Jessup, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejme0907335 · Cited by 18
Lala, A., Beavers, C. J., Blumer, V. L., Brewer, L. C., Oliveira-Gomes, D. D., Dunbar, S. B., Every, H., Ferraro, R., Ky, B., Januzzi, J. L., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101069 · Cited by 19
Gori, M., Redfield, M. M., Calabrese, A., Canova, P. A., Cioffi, G., Maria, R. D., Grosu, A., Fontana, A., Iacovoni, A., Ferrari, P., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1298 · Cited by 17
Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling
von Jeinsen, B., Short, M. I., Larson, M. G., Xanthakis, V., McManus, D. D., Benjamin, E. J., Mitchell, G. F., Aragam, J. R., Cheng, S. C., & Vasan, R. S. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2019.08.001 · Cited by 17
Self-citationZhan, T., Daniyal, M., Li, J., & Mao, Y. (2019) · Herz · doi:10.1007/s00059-018-4779-y · Cited by 17
Jang, S. B., Kim, K. B., Sim, S., et al. (2021) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2021.100224 · Cited by 16
Pezel, T., Bluemke, D. A., Wu, C. O., Lima, J. A. C., & Ambale‐Venkatesh, B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870942 · Cited by 16
Long-term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis
Wong, J. H., Soh, C. H., Wang, B., & Marwick, T. H. (2024) · Heart · doi:10.1136/heartjnl-2024-324301 · Cited by 18
Szmit, S., Jank, M., Maciejewski, H., et al. (2010) · Journal of Applied Genetics · doi:10.1007/bf03208866 · Cited by 16
Chiu, H.-C., Ma, H., Lin, C., Lo, M., Lin, L., Wu, C., Chiang, J., Lee, J.-K., Hung, C., Wang, T., et al. (2017) · Scientific Reports · doi:10.1038/srep43507 · Cited by 16
Self-citationCardio-oncology: protecting the heart from curative breast cancer treatment
Upshaw, J. N. (2018) · Gland Surgery · doi:10.21037/gs.2017.11.09 · Cited by 16
Heart Failure: Who We Treat Versus Who We Study
Miller, L. W. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.10.005 · Cited by 16
Luo, X.-X., Fang, F., So, H., Liu, C., Yam, M. C., & Lee, A. P. (2017) · Echo Research and Practice · doi:10.1530/erp-17-0028 · Cited by 16
Huang, Y., Hsu, Y.-C., Liu, Z., Lin, C., Tsai, R., Chen, J., Chang, P., Liu, H.-T., Lee, W.-C., Wo, H.-T., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1070641 · Cited by 17
Vinereanu, D., MADLER, C., Gherghinescu, C., Ciobanu, A. O., & Fraser, A. G. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01456.x · Cited by 15
Gómez‐Mesa, J. E., Saldarriaga, C., Jurado-Arenales, A. M., et al. (2019) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.06.001 · Cited by 15
Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community
Vasan, R. S., Urbina, E., Jin, L., & Xanthakis, V. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01512-4 · Cited by 15
Self-citationElectrocardiographic Findings Suggestive of Cardiomyopathy
Pelto, H. F., Owens, D. S., & Drezner, J. A. (2013) · Current Sports Medicine Reports · doi:10.1249/jsr.0b013e3182874abb · Cited by 15
Biton, Y., Rosero, S. Z., Moss, A. J., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.11.032 · Cited by 15
Cardiac Target Organ Damage in Hypertension: Insights from Epidemiology
Lawler, P. R., Hiremath, P. G., & Cheng, S. C. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0446-8 · Cited by 15
Aging, Blood Pressure, and Heart Failure
Franklin, S. S., & Levy, D. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179119 · Cited by 15
Self-citationCappellani, D., Marconcini, G., Manetti, L., Bartalena, L., & Bogazzi, F. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac756 · Cited by 14
Subramanian, V., Keshvani, N., Segar, M. W., Kondamudi, N., Chandra, A., Maddineni, B., Matulevicius, S. A., Michos, E. D., Lima, J. A. C., Berry, J. D., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3158 · Cited by 15
Abumayyaleh, M., El‐Battrawy, I., Kummer, M., Pilsinger, C., Sattler, K., Kuschyk, J., Aweimer, A., Mügge, A., Borggrefe, M. M., & Akın, İ. (2021) · Future Cardiology · doi:10.2217/fca-2020-0213 · Cited by 14
CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin
Lang, J. K., Karthikeyan, B., Quiñones‐Lombraña, A., et al. (2021) · Cardio-Oncology · doi:10.1186/s40959-021-00103-0 · Cited by 14
Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age
Leibowitz, D. W., Stessman‐Lande, I., Jacobs, J. M., Cohen, A., Ein‐Mor, E., Stessman, J., & Gilon, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.055 · Cited by 14
Rantner, B., Pohlhammer, J., Stadler, M., Peric, S., Hammerer‐Lercher, A., Klein-Weigel, P. F., Fraedrich, G., Kronenberg, F., & Kollerits, B. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.060 · Cited by 14
Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Reed, B. N., & Sueta, C. A. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x09666131117164352 · Cited by 14
Cheng, H., Chuang, S., Hsu, P., Chou, P., & Chen, C. (2005) · Heart and Vessels · doi:10.1007/s00380-005-0844-6 · Cited by 14
Asymptomatic Left Ventricular Dysfunction
Roger, V. L. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2015.12.007 · Cited by 14
Pre-Heart Failure, Heart Stress, and Subclinical Heart Failure
Bayés‐Genís, A., & Bozkurt, B. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.03.008 · Cited by 14
Liu, W.-T., Hsieh, P.-H., Lin, C.-S., Fang, W.-H., Wang, C.-H., Tsai, C.-S., Hung, Y.-J., Hsieh, C.-B., Lin, C., & Tsai, D.-J. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.11.044 · Cited by 15
Dzudié, A., Abanda, M. H., Nkoké, C., Barche, B. F., Damasceno, A. A. M., Edwards, C., Davison, B. A., Cotter, G., Sliwa, K. S., & THEUS-HF investigators (2020) · ESC Heart Failure · doi:10.1002/ehf2.12903 · Cited by 14
Biomarkers in Acute Heart Failure Syndromes: An Update
Al‐Sadawi, M., Saad, M., Ayyadurai, P., Shah, N., Bhandari, M., & Vittorio, T. J. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666210909170415 · Cited by 15
Chi, R., Shan, X., Guan, C., Yang, H., Wang, X., Li, B., & Zhang, Q. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03403-8 · Cited by 14
Stage B Heart Failure: Rationale for Screening
Atherton, J. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.003 · Cited by 13
Metadata
- Authors
- Wang, T. J., Evans, J. C., Benjamin, E. J., Levy, D., LeRoy, E. C., & Vasan, R. S.
- Affiliations
- Boston University (US)
- Venue
- Circulation
- Published
- 2003-08-26
- Volume
- 108
- Issue
- 8
- Pages
- 977-982
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2095689312
- Semantic Scholar
- c0b4cca1f7420447dfabc94c7398e07a3c8a6163
- Cited by
- 633
- References
- 24
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 28 · 2023: 22 · 2022: 20 · 2021: 45 · 2020: 31 · 2019: 36 · 2018: 29 · 2017: 39 · 2016: 32 · 2015: 21 · 2014: 28 · 2013: 37 · 2012: 36
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23hl074077-03, 5k24hl004334-08, n01hc25195-41-0-1, 5r01ns017950-40)
- National Heart, Lung, and Blood Institute (K23 HL074077-01, K24-HL-04334-01A1, N01‐HC25195)
- National Institute of Neurological Disorders and Stroke (5-R01-NS-17950)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- natural history (disease), congestive heart failure, mortality risk, ejection fraction, Framingham Heart Study, community-based cohort, disease progression
- MeSH terms
- Adult, Aged, Aged, 80 and over, Echocardiography, Female, Follow-Up Studies, Heart Failure, Humans, Male, Massachusetts, Middle Aged, Risk Factors, Stroke Volume, Systole, Cohort Studies, Comorbidity, Incidence, Prevalence, Survival Rate, Proportional Hazards Models, Age of Onset, Age Distribution, Disease Progression, Ventricular Dysfunction, Left, Risk Assessment, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review